Advertisement
UK markets close in 2 hours 1 minute
  • FTSE 100

    8,372.97
    +18.92 (+0.23%)
     
  • FTSE 250

    20,540.61
    +48.62 (+0.24%)
     
  • AIM

    782.76
    +2.93 (+0.38%)
     
  • GBP/EUR

    1.1616
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2500
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    49,101.68
    -582.12 (-1.17%)
     
  • CMC Crypto 200

    1,325.66
    +25.56 (+1.97%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CRUDE OIL

    79.08
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,321.00
    -1.30 (-0.06%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,665.32
    +166.94 (+0.90%)
     
  • CAC 40

    8,159.61
    +28.20 (+0.35%)
     

Ozempic Could Boost Novo Nordisk’s Revenue Growth in 2018

In December 2017, the U.S. FDA (Food and Drug Administration) approved Novo Nordisk’s (NVO) Ozempic as an addition to diet and exercise for the improvement of blood sugar levels in individuals with type ...